A comprehensive approach to determine the probiotic potential of human-derived Lactobacillus for industrial use

Food Microbiology

Volumn 34, Issue 1, 2013, Pages 19-28

  Gregoret, V ^a   Perezlindo, M J ^a   Vinderola, G ^a   Reinheimer, J ^a   Binetti, A ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Functional characterization; Lactobacillus; Probiotics; Technological characterization

Indexed keywords

ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DRUG EFFECT; FECES; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LACTOBACILLUS; MALE; METABOLISM; MICROBIOLOGY; MOUSE; NEWBORN; SMALL INTESTINE;

ANIMALS; ANTI-BACTERIAL AGENTS; FECES; FEMALE; HUMANS; INDUSTRIAL MICROBIOLOGY; INFANT, NEWBORN; INTESTINE, SMALL; LACTOBACILLUS; MALE; MICE; MICE, INBRED BALB C; PROBIOTICS;

LACTOBACILLUS; LACTOBACILLUS GASSERI; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; MUS;

EID: 84870945221     PISSN: 07400020     EISSN: 10959998     Source Type: Journal    
DOI: 10.1016/j.fm.2012.11.004     Document Type: Article

References (52)

1. Ammor M.S., Flórez A.B., Mayo B. Antibiotic resistance in nonenterococcal lactic acid bacteria and bifidobacteria. Food Microbiology 2007, 24:559-570.
2. Binetti A.G., Suárez V.B., Tailliez P., Reinheimer J.A. Characterization of spontaneous phage-resistant variants of Streptococcus thermophilus by RAPD analysis and identification of phage-resistance mechanisms. International Dairy Journal 2007, 17:1117-1122.
3. Briggiler-Marcó M., Capra M.L., Quiberoni A., Vinderola G., Reinheimer J.A., Hynes E. Nonstarter Lactobacillus strains as adjunct cultures for cheese making: in vitro characterization and performance in two model cheeses. Journal Dairy Science 2007, 90:4532-4542.
4. Burns P., Vinderola G., Binetti A., Quiberoni A., de los Reyes-Gavilán C.G., Reinheimer J. Bile-resistant derivatives obtained from non-intestinal dairy lactobacilli. International Dairy Journal 2008, 18:377-385.
5. Burns P., Vinderola G., Molinari F., Reinheimer J. Suitability of whey and buttermilk for the growth and frozen storage of probiotic lactobacilli. International Journal of Dairy Technology 2008, 61(2):156-164.
6. Cataloluk O., Gogebakan B. Presence of drug resistance in intestinal lactobacilli of dairy and human origin in Turkey. FEMS Microbiology Letters 2004, 236:7-12.
7. Champagne C., Ross R., Saarela M., Flemming K., Charalampopoulos H. Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices. International Journal of Food Microbiology 2011, 149:185-193.
8. Collins J.K., Thornton G., Sullivan G.O. Selection of probiotic strains for human applications. International Dairy Journal 1998, 8:487-490.
9. Comunian R., Daga E., Dupre I., Paba A., Devirgiliis C., Piccioni V., Perozzi G., Zonenschain D., Rebecchi A., Morelli L., De Lorentiis A., Giraffa G. Susceptibility to tetracycline and erythromycin of Lactobacillus paracasei strains isolated from traditional Italian fermented foods. International Journal of Food Microbiology 2010, 138:151-156.
10. Devirgiliis C., Caravelli A., Coppola D., Barile S., Perozzi G. Antibiotic resistance and microbial composition along the manufacturing process of Mozzarella di Bufala Campana. International Journal of Food Microbiology 2008, 128:378-384.
11. Edwards U., Rogall T., Blockerl H., Emde M., Bottger E. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Research 1989, 17(19):7843-7853.
12. Europenan Food Safety Authority (EFSA) Technical guidance prepared by the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) on the update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA Journal 2008, 732:1-15.
13. Ezendam J., van Loveren H. Probiotics: immunomodulation and evaluation of safety and efficacy. Nutrition Reviews 2006, 64:1-14.
14. FAO/WHO, 2002. Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report. Available from: http://www.fao.org/es/ESN/food/foodandfood_probio_en.stm.
15. Forssten S.D., Sindelar C.W., Ouwehand A.C. Probiotics from an industrial perspective. Anaerobe 2011, 17:410-413.
16. Gómes A.M., Teixeira M.G., Malcata F.X. Viability of Bifidobacterium lactis and Lactobacillus acidophilus in milk: sodium chloride concentration and storage temperature. Journal of Food Processing and Preservation 1998, 22:221-240.
17. Huey B., Hall J. Hypervariable DNA fingerprinting in E. coli minisatellite probe from bacteriophage M13. Journal of Bacteriology 1989, 171:2528-2532.
18. Huys G., D'Haene K., Danielsen M., Mättö J., Egervärn M., Vandamme P. Phenotypic and molecular assessment of antimicrobial resistance in Lactobacillus paracasei strains of food origin. Journal of Food Protection 2008, 71(2):339-344.
19. Kaila M., Isolauri E., Soppi E., Virtanen E., Laine S., Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatric Research 1992, 32(2):141-144.
20. Kataria J., Li N., Wynn J.L., Neu J. Probiotic microbes: do they need to be alive to be beneficial?. Nutrition Reviews 2009, 67:546-550.
21. Kato I., Yokokura T., Mutai M. Macrophage activation by Lactobacillus casei in mice. Microbiology and Immunology 1983, 16:500-507.
22. Kirjavainen P.V., Salminen S.J., Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. Journal of Pediatric Gastroenterology and Nutrition 2003, 36:223-227.
23. López P., Gueimonde M., Margolles A., Suaréz A. Different Bifidobacterium strains drive different immune responses in vitro. International Journal of Food Microbiology 2010, 138:157-163.
24. MacPherson A.J., Hunziker L., McCoy K., Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes and Infection 2001, 3:1021-1035.
25. Marteau P., Minekus M., Havennar R., Huis in't Veld J.H.J. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. Journal of Dairy Science 1997, 80:1031-1037.
26. Marteau P., Pochart P., Flourie B., Pellier P., Santos L., Desjeux J.F., Rambaud J.C. Effect of chronic ingestion of fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities on the colonic flora in humans. American Journal of Clinical Nutrition 1990, 52:685-688.
27. Martínez-Cañaavate A., Sierra S., Lara-Villoslada F., Romero J., Maldonado J., Boza J., Xaus J., Olivares M. A probiotic dairy product containing L. gasseri CECT5714 and L. coryniformis CECT5711 induces immunological changes in children suffering from allergy. Pediatric Allergy and Immunology 2009, 20:592-600.
28. Noriega L., Gueimonde M., Sánchez B., Margolles A., de los Reyes-Gavilán C. Effect of the adaptation to high bile salts concentrations on glycosidic activity, survival at low pH and cross resistance to bile salts in Bifidobacterium. International Journal of Food Microbiology 2004, 94:79-86.
29. O'Toole P., Claesson M. Gut microbiota: changes throughout the lifespan from infancy to elderly. Review. International Dairy Journal 2010, 20:281-291.
30. Ouwehand A.C., Salminen S.J. The health effects of cultured milk products with viable and non-viable bacteria. International Dairy Journal 1998, 8:749-758.
31. Paturi G., Phillips M., Jones M., Kailasapathy K. Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in mice. International Journal of Food Microbiology 2007, 115:115-118.
32. Pavan S., Desreumaux P., Mercenier A. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clinical and Diagnostic Laboratory Immunology 2003, 10:696-701.
33. Perdigón G., de Macías M.E., Álvarez S., Oliver G., de Ruíz Holgado E. Effect of perorally administered lactobacilli on macrophage activation in mice. Infection and Immunity 1986, 53(2):404-410.
34. Reid G. The importance of guidelines in the development and application of probiotics. Current Pharmaceutical Design 2005, 11:11-16.
35. Reid G., Jass J., Sebulsky M.T., McCormick J.K. Potential uses of probiotics in clinical practice. Clinical and Microbiology Reviews 2003, 16:658-672.
36. Reinheimer J.A., Renzulli P.M., Rubiolo A.C., Bailo N.B., Binetti A.G. Effects of sodium and potassium chloride on growth and acid production in thermophilic lactic acid bacteria. Microbiologie-Aliments-Nutrition 1997, 15:7-15.
37. Saarela M.H., Alakomi H.L., Puhakka A., Mättö J. Effect of the fermentation pH on the storage stability of Lactobacillus rhamnosus preparations suitability of in vitroanalyses of cell physiological functions to predict it. Journal of Applied Microbiology 2009, 106:1204-1212.
38. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. third ed.
39. Santosa S., Farnworth E., Jones P.J.H. Probiotics and their potential health claims. Nutrition Reviews 2006, 64:265-274.
40. Sartor R.B. Probiotic therapy of intestinal inflammation and infections. Current Opinion in Gastroenterology 2004, 21:44-50.
41. Stanton C., Desmond C., Coakley M., Collins J.K., Fitzgerald G., Ross R.P. Challenges facing development of probiotic-containing functional foods. Handbook of Fermented Functional Foods 2003, 27-58. CRC Press, Boca Raton, Florida. E.R. Farnworth (Ed.).
42. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. Journal of Pediatrics 2001, 138:361-365.
43. Tannock G.W. The intestinal microflora. Gut Flora, Nutrition, Immunity and Health 2003, 1-23. Balckwell Publishing, Oxford, United Kingdom. R. Fuller, G. Perdigón (Eds.).
44. Tsai Y., Cheng P., Liao J., Pan T. Effect of the administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity. International Immunopharmacology 2010, 10(7):791-798.
45. Usman A., Hosono A. Viability of Lactobacillus gasseri and its cholesterol-binding and antimutagenic activities during subsequent refrigerated storage in nonfermented milk. Journal of Dairy Science 1999, 82:2536-2542.
46. Vankerckhoven V., Huys G., Vancanneyt M., Vael C., Klare I., Romond M.-B., Entenza J., Moreillon P., Wind R., Knol J., Wiertz E., Pot B., Vaughan E., Kahlmeter G., Goossens H. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends in Food Science and Technology 2008, 19:102-114.
47. Vinderola G., Capellini B., Villarreal F., Suárez V., Quiberoni A., Reinheimer J. Usefulness of a set of simple in vitro tests for the screening and identification of probiotic candidate strains for dairy use. LWT - Food Science and Technology 2008, 41:1678-1688.
48. Vinderola G., Céspedes M., Mateolli D., Cárdenas P., Lescano M., Aimaretti N., Reinheimer J. Changes in gastric resistance of Lactobacillus casei in flavoured commercial fermented milks during cold storage. International Journal of Dairy Technology 2011, 64(2):269-275.
49. Vinderola G., Reinheimer J.A. Enumeration of Lactobacillus casei in the presence of Lact. acidophilus, bifidobacteria and lactic starter bacteria in fermented dairy products. International Dairy Journal 2000, 10:271-275.
50. Vintiñi E., álvarez S., Medina M., Médici M., de Budeguer M., Perdigón G. Gut mucosal immunostimulation by lactic acid bacteria. Biocell 2000, 23:223-232.
51. Xanthopoulos V., Litopoulou-Tzanetaki E., Tzanetakis N. Characterization of Lactobacillus isolates from infant faeces as dietary adjuncts. Food Microbiology 2000, 17:205-215.
52. Yan F., Polk D.B. Probiotics: progress toward novel therapies for intestinal diseases. Current Opinion in Gastroenterology 2010, 26:95-101.